Transparency data

Adult reference group

Updated 23 April 2025

© Crown copyright 2025

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/uk-national-screening-committee-register-of-interests/adult-reference-group

This register records declarations made by members in respect of interests they have that are relevant to the remit of the UK NSC’s adult reference group.

Dr Ros Given-Wilson (Chair)

Claire Bailey

  • trustee of Symposium Mammographicum charity

Dr Sunil Bhanot

  • none

Dr Georgia Black

  • works in the Centre for Prevention, Detection and Early Diagnosis, Queen Mary University of London, where many colleagues are involved in research relating to cancer screening programmes

Heidi Douglas

  • employer NHS Tayside provides national bowel cancer screening service in Scotland

Professor Stephen Duffy

  • co-applicant on the PROSPECTS Trial of Digital Breast Tomosynthesis in breast cancer Screening, which receives a research grant from Hologic Inc
  • occasional paid consultancy on methodology and data interpretation for GRAIL
  • occasional paid consultancy on methodology for Roche

Professor Gareth Evans

  • AstraZeneca (consultancy fee: genetic testing for PARPi treatment) and Springworks (consultancy fee: drug treatment trial advice)
  • registrable shareholding: Tesco and M&S
  • Syantra: advisory role for blood test to detect breast cancer

Professor Allan Hacksaw

  • investigator for SUMMIT lung cancer screening study sponsored by UCL and funded by GRAIL
  • received honorarium for advisory board meeting for GRAIL in 2018
  • received consulting fee from Evidera Inc for a GRAIL-initiated project in 2020
  • unpaid collaboration on joint academic projects with GRAIL
  • unpaid member of MCDs advisory boards for Roche, Adela Bio and Luventix

Professor Steve Halligan

  • none

John Hitchman (PPV)

  • none

Christopher Hughes

  • none

Rebecca Maclean

  • none

Dr Jim McMorran

  • participation in GRAIL Primary Care Advisory Group

Prof Sarah Pinder

  • Advisory Boards, Honoraria for educational events from Exact Science, Roche and AstraZeneca
  • Member of:
    • National Coordinating Committee for Breast Pathology (Chair) (Royal College of Pathologists and NHS BSP)
    • Sloane Project Steering Committee
    • UK Interdisciplinary Breast Cancer Symposium
    • OPTIMA Trials Management Group
    • MAMMO50 Trial Management Groups
    • Low risk DCIS trial (LORIS) Clinical Trial Management Group
    • NOSTRA Clinical Trial Management Group
    • SMALL Clinical Trial Management Group
    • EndoNET Clinical Trial Management Group
    • various breast pathology groups, including Association of Breast Pathology (Vice-President)
  • via King’s College London, grant funding is received from:
    • Cancer Research UK
    • National Institute for Health Research
    • Wellcome Leap Inc
    • Medical Research Council
  • undertaking research with Paige AI and have undertaken research in the past with Panakeia Technologies (no financial interest with either)

Margaret Powell (PPV)

  • none

Dr Katie Robb

  • none

Dr Chris Stinton

  • employed by the University of Warwick, which is an approved supplier of reviews for the UK NSC

Lynda Williams

  • chair and trustee of registered charity SWS Cymru (Support With Scoliosis)

Prof Allan Wilson

  • past president of the Institute of Biomedical Science

  • executive member of the British Association for Cytopathology

Dr Stuart Wright

  • co-applicant on a research grant funded by Cancer Research UK: A Case Control Study of women aged 30-39 to augment breast cancer risk prediction and assess acceptability and preference of a systematic risk prediction approach through primary care (BCAN-RAY)
Back to top